HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 262 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,628,756 | +72.3% | 1,025,402 | +53.2% | 0.01% | +85.7% |
Q2 2023 | $68,855,709 | -73.5% | 669,477 | -71.9% | 0.01% | -74.1% |
Q1 2023 | $260,145,560 | +51.7% | 2,383,595 | +58.2% | 0.03% | +35.0% |
Q4 2022 | $171,439,587 | +119.7% | 1,506,499 | +19.5% | 0.02% | +122.2% |
Q3 2022 | $78,036,000 | -36.0% | 1,260,889 | -17.5% | 0.01% | -35.7% |
Q2 2022 | $121,886,000 | -16.7% | 1,528,144 | +9.9% | 0.01% | 0.0% |
Q1 2022 | $146,335,000 | -14.7% | 1,390,895 | -12.6% | 0.01% | -17.6% |
Q4 2021 | $171,584,000 | -4.3% | 1,592,264 | -2.8% | 0.02% | -10.5% |
Q3 2021 | $179,358,000 | +9.4% | 1,637,375 | -6.5% | 0.02% | +11.8% |
Q2 2021 | $163,922,000 | -0.4% | 1,750,557 | -2.1% | 0.02% | -5.6% |
Q1 2021 | $164,593,000 | +34.1% | 1,788,273 | +6.5% | 0.02% | +12.5% |
Q4 2020 | $122,777,000 | +30.0% | 1,678,454 | +38.1% | 0.02% | +33.3% |
Q3 2020 | $94,426,000 | +67.7% | 1,215,580 | +20.0% | 0.01% | +50.0% |
Q2 2020 | $56,298,000 | +94.3% | 1,012,924 | +3.6% | 0.01% | +60.0% |
Q1 2020 | $28,973,000 | -11.7% | 978,185 | +7.9% | 0.01% | 0.0% |
Q4 2019 | $32,826,000 | +61.0% | 906,783 | +21.1% | 0.01% | +66.7% |
Q3 2019 | $20,390,000 | -20.8% | 748,774 | -30.0% | 0.00% | -25.0% |
Q2 2019 | $25,731,000 | – | 1,069,409 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |